Seytri-T 1.125 Vial (1×1 Vial)
Product Overview
Seytri-T 1.125 Vial is a broad-spectrum antibiotic injection formulated to combat a wide range of bacterial infections. It combines the powerful action of Ceftriaxone (1 g) and Tazobactam (125 mg) to deliver effective treatment against both gram-positive and gram-negative bacteria. This combination helps manage infections of the lungs, urinary tract, skin, soft tissues, abdomen, bones, joints, and reproductive system, as well as severe infections like meningitis and septicemia.
How It Works
This dual-action antibiotic works by inhibiting bacterial cell wall synthesis through Ceftriaxone, leading to the destruction of harmful microorganisms. Tazobactam enhances this effect by blocking beta-lactamase enzymes, which protect bacteria from antibiotic action. Together, they ensure stronger and longer-lasting antibacterial protection while minimizing the risk of resistance.
Key Benefits
Provides powerful protection against a wide range of bacterial infections
Combines two active ingredients for enhanced effectiveness
Helps prevent infection recurrence and bacterial resistance
Offers quick relief from infection-related symptoms such as fever, pain, and inflammation
Suitable for hospital-acquired and community-acquired infections
Administered under medical supervision for safe and precise dosage
Uses of Seytri-T 1.125 Vial
Respiratory infections (pneumonia, bronchitis)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Bone and joint infections
Intra-abdominal and pelvic infections
Septicemia and meningitis
Post-surgical or wound infections
Dosage and Administration
Seytri-T 1.125 Vial is intended for intravenous (IV) or intramuscular (IM) administration and should be given only by a healthcare professional. The dosage and duration are determined by the doctor based on the infection type, severity, and patient’s health status. It is important to complete the full course as prescribed to ensure full recovery and prevent the development of antibiotic resistance.
Possible Side Effects
While Seytri-T 1.125 is generally well tolerated, some individuals may experience mild or temporary effects such as:
Pain or swelling at the injection site
Nausea or vomiting
Diarrhea
Skin rash or itching
Headache or dizziness
In rare cases, serious allergic reactions may occur. Seek immediate medical help if you experience difficulty breathing, swelling, or severe skin reactions.
Safety & Precautions
Prescription Required: Use only under medical guidance.
Alcohol: Avoid alcohol during treatment to reduce unwanted side effects.
Pregnancy & Breastfeeding: Consult your doctor before use.
Kidney or Liver Impairment: Dose adjustments may be needed; medical monitoring is advised.
Driving: If you feel dizzy or unwell after injection, avoid driving or operating heavy machinery.
Hydration: Maintain adequate fluid intake to support recovery and medication effectiveness.
Storage Instructions
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use if the vial appears damaged or past the expiry date.
Why Choose Seytri-T 1.125 Vial
Trusted antibiotic combination for comprehensive infection control
Clinically proven formula for rapid bacterial elimination
Manufactured under strict pharmaceutical standards to ensure safety and efficacy
Reliable choice for healthcare professionals and hospitals
Product Variants & Keywords
Seytri-T 1.125 Vial | Seytri T Injection | Seytri T 1.125 IV | Seytri-T 1.125 Antibiotic | Seytri T Ceftriaxone and Tazobactam Injection | Seytri-T 1.125 gm Vial | Seytri T 1.125 mg | Seytri T Injection 1g + 125mg



Reviews
There are no reviews yet.